Long ignored by drugmakers, preeclampsia is now a focus for WHO and biopharma
A pregnancy-related hypertension disorder that impacts millions of mothers and newborns each year is getting more attention from the top levels of public health organizations and a few biopharma companies. The World Health Organization on ...
We haven't written up this one. Endpoints News has the full story — the link below goes straight to it.